Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx)
- 1 April 2017
- journal article
- practice guideline
- Published by Elsevier BV in Therapies
- Vol. 72 (2), 185-192
- https://doi.org/10.1016/j.therap.2016.09.014
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel DiseaseGastroenterology, 2015
- UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practiceFundamental & Clinical Pharmacology, 2015
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 UpdateClinical Pharmacology & Therapeutics, 2014
- CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study PopulationsClinical Pharmacology & Therapeutics, 2013
- DPYD IVS14+1G>A and 2846A>T Genotyping for the Prediction of Severe Fluoropyrimidine-Related Toxicity: A Meta-AnalysisPharmacogenomics, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.JNCI Journal of the National Cancer Institute, 2012
- CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 TrialJNCI Journal of the National Cancer Institute, 2012
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) GenotypeClinical Pharmacology & Therapeutics, 2011
- Codeine Intoxication Associated with Ultrarapid CYP2D6 MetabolismThe New England Journal of Medicine, 2004